Loading
NextCell Pharma AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 27 May 2025.
NextCell Pharma AB: what insiders have been doing
NextCell Pharma AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. The past year has been quiet: not a single insider filing for NextCell Pharma AB. The previous disclosure was published on 3 June 2025.
The full history, which starts in 2021, counts 3 purchases against 1 sale.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€1,196
3 ops. · all time
Sell Volume
€93,715
1 ops. · all time
Who traded when
BuySalePatrik Fagerholm3 buys
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 1.01
Analyst consensus
1 analystsSEK 3.50Target SEK 3.50(+246%)SEK 3.50
Income statement
RevenueSEK 10M
Gross profitSEK 1.6M16% margin
EBITDA-SEK 36.9M-370% margin
Net income-SEK 39.4M-395.2% margin
Valuation
P/Book2.3x
Beta0.73
Balance sheet & cash
Market capSEK 112.7M
Free Cash Flow-SEK 37.9M
Profitability & ownership
% insiders29.7%
% institutions6.6%
Last declaration on 3 June 2025
Declarations10 total
62,894 shares0OptionFI:A003P257-1
454,019 shares0OptionFI:A003P256-1
62,894 shares@ SEK 1.000.057% mcap12.2% of flowAktieISIN SE0009723125FI:A003P238-2
454,019 shares@ SEK 1.000.41% mcap87.8% of flowAktieISIN SE0009723125FI:A003P236-2
298,440 shares@ SEK 1.000.27% mcap95.4% of flowAktieISIN SE0009723125FI:A003P179-2
1,320 shares@ SEK 1.000.0012% mcap0.4% of flowAktieISIN SE0009723125FI:A003P178-2
20,000 shares@ SEK 0.0050.0001% mcap0.0% of flowTeckningsoptionISIN SE0022240800FI:A003O981-1
Canonical exit: 25 Aug 2025 (T+90)
50,000 shares@ SEK 0.080.0036% mcap1.3% of flowTeckningsoptionISIN SE0022240800FI:A003O080-1
Canonical exit: 7 Aug 2025 (T+90)
100,000 shares@ SEK 0.090.0081% mcap2.9% of flowTeckningsoptionISIN SE0022240800FI:A003N606-1
Canonical exit: 27 Jul 2025 (T+90)
60,000 shares@ SEK 15.80100.0% of flowAktieISIN SE0009723125FI:A001P854-1
10 of 10 declarations
About NextCell Pharma AB
NextCell Pharma AB is a biotechnology company focused on developing cell therapies for the treatment of type 1 diabetes. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
